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Abstract
A nested polymerase chain reaction (nPCR)-based assay, was developed and evaluated for rapid
detection of Trypanosoma evansi in experimentally infected mice and naturally infected camels
(Camelus dromedarius). Four oligonucleotide primers (TE1, TE2, TE3 and TE4), selected from
nuclear repetitive gene of T. evansi, were designed and used for PCR amplifications. The first
amplification, using a pair of outer primers TE1 and TE2, produced a 821-bp primary PCR product
from T. evansi DNA. The second amplification, using nested (internal) pair of primers TE3 and TE4,
produced a 270-bp PCR product. T. evansi DNAs extracted from blood samples of experimentally
infected mice and naturally infected Sudanese breed of dromedary camels were detected by this
nested PCR-based assay. The nested primers TE3 and TE4 increased the sensitivity of the PCR
assay and as little as 10 fg of T. evansi DNA (equivalent to a single copy of the putative gene of the
parasite) was amplified and visualized onto ethidium bromide-stained agarose gels.
Amplification products were not detected when the PCR-based assay was applied to DNA from
other blood parasites including Thieleria annulata, Babesia bigemina or nucleic acid free samples.
Application of this nPCR-based assay to clinical samples resulted in direct detection of T. evansi
from a variety of tissue samples collected from experimentally infected mice and blood from
naturally infected camels. The described nPCR-based assay provides a valuable tool to study the
epidemiology of T. evansi infection in camels and other susceptible animal populations.
Background
Trypanosoma evansi (T. evansi), the cause of trypanosomia-
sis (Surra), constitutes one of the major veterinary prob-
lems worldwide. The disease causes significant morbidity
and mortality in camels in the Sudan, which has a popu-
lation of over 3 million camels [1]. trypanosomiasis in
camels occurs both in chronic and acute forms [2]. The
chronic form of the disease is most common and is likely
to be associated with secondary infections due to immu-
nosuppression [3]. Clinical signs and pathological lesions
caused by T. evansi in camels are unreliable for definitive
diagnosis [4]. In addition, detection of parasites in the
blood is difficult because parasitaemia is intermittent [5].
Serological tests have been developed and evaluated for
diagnosis of trypanosomiasis in camels. They include card
agglutination test and enzyme-linked immunosorbent
assay (Ab-ELISA) [6-8]. In general serological techniques
are useful for detection of a past infection but not for
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detection of an active infection with T. evansi. To address
these problems, nucleic acid hybridization probes have
been developed and evaluated for detection of T. evansi.
However, the concentration of T. evansi DNA in suspected
samples may be below the detection limit of the hybridi-
zation assay and hence positive cases are likely to be
missed [9]. It is, therefore, becoming increasingly obvious
that the development of molecular diagnostic techniques
for rapid, sensitive and specific detection of T. evansi
would be advantageous in a variety of circumstances
including clinical disease investigation and epidemiologic
surveys for the disease as well as in control programs.
Recently, the polymerase chain reaction (PCR) has been
widely used as highly sensitive and specific assay for detec-
tion of trypanosomes. Primers targeting subgroup
Trypanozoon were previously described [10,11]. In addi-
tion, nuclear repetitive T. evansi specific PCR assays have
also been developed [10-12]. The PCR has been used in
surveys to determine the prevalence of T. evansi in camels
from different regions in Kenya [3] and in buffaloes in
Vietnam (Holland et al., 2001) and T. equiperdum in Mon-
golian horses [13]. However, PCR has not been systemat-
ically used for the detection of T. evansi in camels in
Sudan. In this study, we described a simple, rapid, sensi-
tive and specific assay for detection of T. evansi in Suda-
nese breed of dromedary camels (Camelus dromedarius)
using nPCR amplification.
Results
The nPCR-based assay afforded sensitive and specific
detection of all T. evansi strains obtained from experimen-
tally infected mice and naturally infected camels. The
outer pair of primers TE1 and TE2 produced a primary
810-bp PCR product from T. evansi DNA. The primary
810-bp PCR product was visualized on ethidium bro-
mide-stained gel from ≥ 10 pg of T evansi DNA. (Figure 1).
Using the nested primers (T3 and T4), the PCR assay
resulted in amplification of a 270 bp PCR product from
the primary PCR product. The nested 270 bp PCR product
was detected from as little as as 10 fg of T. evansi DNA
(equivalent to a single copy of nuclear repetitive gene of T.
evansi). The nested amplification increased the sensitivity
of the PCR assay and confirmed the identity of the nucle-
otide sequences of the primary amplified PCR product
(Figure 2).
The amount of 1.0 ng DNA from other blood parasites
including  Thieleria annulata, Babesia bigemina; nucleic
acid-free samples, blood and tissue samples from unin-
fected mice and camels failed to produce the primary or
the nested amplification products (Figure 3). The specific
PCR products were detected directly from a variety of
infected tissue samples including, unfractionated lysed
blood, spleen, lung and liver homogenates from experi-
mentally infected mice (Figure 4) and from blood of nat-
urally infected camels (Figure 5). Using the pair of primers
semi-nested 1 (TE1 and TE4), the PCR assay resulted in
amplification of a 490-bp PCR product. Likewise, the use
of pair of primers semi-nested 2 (TE3 and TE2) produced
a 590-bp PCR product (figure 6).
Discussion
The economic importance of T. evansi infection is mainly
attributed to clinical disease in camels in many parts of
the world [14-18]. PCR has been used successfully in
Amplifcation of the nested 270-bp specific-PCR product on  ethidium-bromide-stained agarose gel from 10 fg of T. evansi  DNA Figure 2
Amplifcation of the nested 270-bp specific-PCR prod-
uct on ethidium-bromide-stained agarose gel from 
10 fg of T. evansi DNA. Lane MW: molecular weight 
marker (1 Kb ladder); Lane 1–7: T. evansi DNA at a concen-
tration of 10 ng, 1.0 ng, 100 pg, 10 pg, 1 pg, 100 fg, 10 fg, 
respectively.
MW             1               2             3            4      5               6              7
517 bp
Visualization of the primary 810-bp PCR product onto ethid- ium-bromide-stained agarose gel from 10 pg of DNA of T.  evansi Figure 1
Visualization of the primary 810-bp PCR product 
onto ethidium-bromide-stained agarose gel from 10 
pg of DNA of T. evansi. Lane MW: molecular weight 
marker (1 Kb ladder); Lane 1–7: T. evansi DNA at a concen-
tration of 10 ng, 1.0 ng, 100 pg, 10 pg, 1 pg, 100 fg, 10 fg, 
respectively.Kinetoplastid Biology and Disease 2006, 5:2 http://www.kinetoplastids.com/content/5/1/2
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detecting infection with T. evansi in buffaloes [12,19],
horses [13] and in camels [11]. So far, there is no compre-
hensive data on the use of PCR for detecting infection in
Sudanese breed of dromedary camels (Camelus dromedar-
ius). In the absence of other diagnostic techniques, the
camel owners and ethno-veterinarians rely on the smell of
urine for diagnosis of T. evansi infections. The characteris-
tic smell of urine is due to ketones produced after break-
down of amino acids by the parasite in infected animals
[20].
Conventional parasitological techniques will remain
important for understanding the biology, ecology and
molecular epidemiology of different strains of the para-
sites. The described nPCR assay provides simple, rapid,
sensitive and specific method for detection of T. evansi in
naturally infected camels (Camelus dromedarius) and can
be recommended for inclusion in survey and control pro-
grammes. The nPCR-based assay using primers derived
from nuclear repetitive gene of T. evansi reproducibly and
specifically detected all strains of the parasite used in this
study. Selection of these universal primers was based on
the observation that the nuclear repetitive gene has highly
conserved nucleotide sequences [11]. The nPCR assay was
a simple procedure that efficiently detected all T. evansi
strains under the stringency condition used in this study.
The laboratory detection limit indicated that the nPCR
protocol was capable of detecting the amount of 10 fg of
total T. evansi genomic DNA.
The specificity studies indicated that the primary specific
821-bp and the nested 270-bp PCR products were not
amplified even from concentrations of 10 ng of DNA from
other blood parasite including Thieleria annulata, Babesia
bigemina and blood cells from non infected mice and cam-
els under the same stringency condition described in this
study. Based on these sensitivity and specificity results of
this study, the described nPCR should be considered as
the most highly sensitive and specific assay compared to
the previously described PCR-based detection assays
[10,12,13,19]. The second amplification step using the
nested primers TE3 and TE4 is necessary to confirm the
specificity of the primary amplified product and to
increase the sensitivity of the PCR-based assay by at least
1000 times particularly, when the concentration of the T.
evansi DNA in the sample is less than 10 pg. The use of
nested amplification for confirmatory diagnosis of T.
evansi  infection renders this PCR assay a rapid and an
inexpensive assay. The nested PCR does not required
hybridization assay and this removes the hazardous and
cumbersome radioactive laboratory procedures of work-
ing with 32P or 33P in hybridization assays [23]. Successful
amplification was also obtained from tissue samples from
whole blood of experimentally infected mice, unlike other
PCR assays where fractionation of blood leukocyte was
necessary for detection of the parasite DNA [10]. Sample
preparation and DNA extraction using QIAamp extraction
kit was a simple procedure, which takes one hour. The
thermal cycling profiles for production of the primary and
the nPCR products were consistently 4 hours. Running of
the agarose gel and electrophoresis usually takes one
hour. Thus, confirmatory diagnosis of T. evansi infection
Detection of the 810-bp T. evansi PCR product from tissue  samples collected from experimentally infected mice Figure 4
Detection of the 810-bp T. evansi PCR product from 
tissue samples collected from experimentally 
infected mice. Lane MW: molecular weight marker (1 Kb 
ladder); Lane 1: blood samples, Lane 2: spleen; Lane 3: liver; 
Lane: blood from non infected mouse, Lane 5: blood from 
non infected camel (negative controls).
Specificity of the polymerase chain reaction for T. evansi. The  810-bp PCR amplification product was not detected from 1.0  ng of DNA extracted from Babesia and Theileria spp Figure 3
Specificity of the polymerase chain reaction for T. 
evansi. The 810-bp PCR amplification product was 
not detected from 1.0 ng of DNA extracted from 
Babesia and Theileria spp. Lane MW: molecular weight 
marker (1 Kb ladder); Lane 1: 1.0 ng of T. evansi DN (positive 
control), Lane 2: 1.0 pg DNA of Theileria anulata, Lane 3: 1.0 
pg DNA of Babesia bigemina, Lane 4: nucleic acid free sample 
(negative control).Kinetoplastid Biology and Disease 2006, 5:2 http://www.kinetoplastids.com/content/5/1/2
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using the described nPCR assay could be made within the
same working day.
Cross contamination in nPCR amplification reactions is
also a problem. The problem of contamination could be
minimized by using nucleic acid-free aerosol resistant tips
and separate rooms for DNA extraction and amplification.
Negative and positive controls should be included in each
PCR assay to maintain the higher limit of sensitivity and
the lower limit of specificity. The rapidity, sensitivity and
specificity of the nPCR assay would greatly facilitate rapid
detection of early or chronic infection with T. evansi in
camels and other susceptible animals. Application of this
nested PCR on a practical scale to determine the preva-
lence of T. evansi in naturally infected camels in different
states of Sudan is in progress.
Conclusion
The described nPCR assay, using well characterized T.
evansi-specific primers, provides a simple, rapid, sensitive
and specific detection of T. evansi in naturally infected
camels (Camelus dromedarius) and can be used as a valua-
ble tool during epidemiological surveys and control pro-
grammes.
Methods
Collection of blood samples
Blood samples were collected in clean sterile vacutainers,
containing ethylene diamine tetra acetic acid (EDTA),
from experimentally infected mice and from naturally
infected camels. The blood samples were used for extrac-
tion of total nucleic acids for use as target DNA for PCR
amplification.
Parasitological examination and mouse inoculation
Two capillary tubes were prepared from each heparinised
blood sample and centrifuged in a microhaematocrit cen-
trifuge for 5 min at 12,000 g. The capillary tubes were
examined for the presence of motile trypanosomes using
the microhaematocrit centrifugation technique. Four
hundred microlitres of blood from infected camels were
inoculated into Swiss-bred mice, which were screened for
infection with T. evansi by wet smear examination of tail-
tip blood every day for detection of parasitaemia.
Extraction of DNA from blood samples
Whole blood was used for extraction of total genomic
DNA using commercially available QIAamp blood kit
(QIAGEN Inc. Chatsworth, CA, USA) according to the
manufacturer's instructions. Briefly, 200 µl of whole
blood, 20 µl of proteinase K stock solution, and 200 µl of
lysing buffer were pipetted into 1.5 ml eppendorf tube
and the mixture was incubated at 37°C for 30 minutes
and then at 70°C for 10 minutes. 200 µl of absolute eth-
anol was added to the sample and the mixture was mixed
by vortexing and spinning. The mixture was transferred to
the QIAspin column, and placed in a clean 2 ml collection
tube and centrifuged at 8000 g for 1 minute. The QIAspin
column was washed twice using 500 µl of washing buffers
W1 and W2, respectively. The QIAamp spin column was
then placed in a clean 1.5 ml eppendorf tube and the DNA
was eluted with 200 µl double distilled water preheated at
70°C. Maximum DNA yield was obtained by spinning at
12,000 g for 1 min. The DNA concentration was deter-
mined by spectrophotometer at 260 nm wave length. Five
µl of the extracted DNA was used in the PCR amplifica-
tion.
Detection of T. evansi DNA by PCR using four different prim- ers Figure 6
Detection of T. evansi DNA by PCR using four differ-
ent primers. Lane MW: molecular weight marker (1 Kb 
ladder); Lane 1: amplification of the primary 810 bp-PCR 
product using the outer pair of primers (TE1 and TE2); Lane 
2: amplification of the nested 270-bp PCR product using the 
internal pair of primers (TE3 and TE4); Lane 3: amplification 
of the semi-nested 490-bp PCR product using the pair of 
primers semi-nested 1 (TE1 and TE4); Lane 4: amplification 
of the semi-nested 590-bp PCR product using the pair of 
primers semi-nested 2 (TE3 and TE2). Lane 5: primers-free 
PCR amplification (negative control).
Detection of the 810-bp T. evansi PCR product from blood  samples collected from naturally infected camels Figure 5
Detection of the 810-bp T. evansi PCR product from 
blood samples collected from naturally infected cam-
els. Lane MW: molecular weight marker (1 Kb ladder); Lane 
1–7: blood samples from naturally infected camels.Kinetoplastid Biology and Disease 2006, 5:2 http://www.kinetoplastids.com/content/5/1/2
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Extraction of DNA from tissue samples
Five ml distilled water was added to 1 gm of each tissue
sample collected from lungs, Liver and spleen of experi-
mentally infected mice. The tissue sample was then mixed
by homogenization. The homogenate was treated by
freezing and thawing and finally centrifuge at 3000 RPM
for 10 minutes. 200 µl of the supernatant was used for
DNA extraction following the same procedure used for
extraction of DNA from blood as described above.
Primers selection
Primers (TE1 and TE2) were selected from a highly con-
served region of the published sequence of nuclear repet-
itive gene of Indonesian strain of T. evansi [24]. This pair
of primers was used for the synthesis of the primary PCR
amplification product. TE1 included bases 91–110 of the
positive sense strand of T. evansi putative gene (5)-AGG
ACG CAG AAA TAG CAG TA-(3). TE2 included bases
881–900 of the complementary strand: (5)-ATT TAA TTG
AGT GGC GTG AG-(3). The PCR using primer TE1 and
TE2 will result in a 810-bp PCR product. For the nested
amplification step, oligonucleotide primers (TE3 and
TE4) were selected from the same published sequence
cited above. TE3 consisted of bases 311–330 of the posi-
tive strand (5)-CTT TTA TAC GAG GAG AGG GA-(3). TE4
was designed from the complementary strand between
bases 561–580 (5)-TAT GGG CGT GCA GAT TTC AC-(3).
PCR amplification using TE3 and TE4 will result in a 270
bp PCR product, internal to the annealing sites of TE1 and
TE2. Using the semi-nested pair of primers (TE1 and TE4),
the PCR assay will result in amplification of a 490-bp
semi-nested PCR product. The pair of semi-nested primers
(TE3 and TE2) will be expected to produce a 590-bp semi-
nested PCR product. Details for primers design including
position of nucleotides, nucleotide sequences, and
expected PCR products are shown in (Table 1).
All primers were synthesized on a DNA synthesizer (Mil-
liigen/Biosearch, a division of Millipore Burlington, MA)
and purified using oligo-pak oligonucleotide purification
columns (Glen Research Corporation, Sterling, VA.) as per
manufacturer's instructions.
Polymerase chain reaction (PCR)
A stock buffered solution containing 250 µl 10× PCR
buffer, 100 µl of magnesium chloride, 12.5 µl of each
dATP, dTTP, dGTP and dCTP was prepared in 1.5 ml
eppendorf tube. The primers were used at a concentration
of 20 pg/µl, and double distilled water was added to bring
the volume of the stock buffer solution to 1.5 ml. Two µl
of primers, 5.0 µl of the target DNA and 42 µl of the stock
solution were added onto 0.5 ml PCR tubes and mixed by
vortexing. One µl of Taq DNA polymerase (Perkin Elmer)
was used at a concentration of 5.0 U/µl. All PCR amplifi-
cation reactions were carried out in a final volume of 50
µl. The thermal cycling profiles were as follows: a 2 min
initial incubation at 95°C, followed by 40 cycles of 95°C
for 1 min, 55°C for 30 sec and 72°C for 45 sec, and a final
incubation at 72° for 10 min. Thermal profiles were per-
formed on a Techne PHC-2 thermal cycler (Techne, Prin-
ceton, NJ.). Following amplification, 15 µl from each PCR
containing amplified product were loaded onto gels of
1.0% SeaKem agarose (FMC Bioproduct, Rockland ME)
and electrophoresed. The gels were stained with ethidium
bromide and T. evansi primary PCR products were easily
identified following visualization under UV light.
Nested Polymerase Chain Reaction (nPCR)
For the nested PCR amplification, 2.0 µl of the primary
amplified product produced by TE1 and TE2 were trans-
ferred to 0.5 ml PCR tube containing (2 µl of nested prim-
ers and; 42 µl of stock PCR buffer and Taq DNA
polymerase was used at a concentration of 5.0 U/µl. The
nested pair of primers (TE3 and TE4) was expected to
amplify a 270 bp PCR product, internal to the annealing
sites of primers PSL1 and PSR2. All PCR amplifications
were carried out in a final volume of 50 µl. The thermal
cycling profiles were as follows: a 2 min incubation at
Table 1: 
Primer Position Nucleic acid sequence PCR product
External (outer primers)
TE1 91–110 (5)-AGGACGCAGAAATAGCAGTA (3) 810-bp
TE2 881–900 (5)-ATTTAATTG AGTGGCGTGAG (3)
Internal (nested Primers)
TE3 311–330 5)-CTTTTATACGAGGAG GGGA (3) 270-bp
TE4 561–580 5)-TATGGGCGTGCAGATTTC AC (3)
Semi-nested 1
TE1 91–110 5)-AGGACGCAGAAATAGCAGTA (3) 490-bp
TE4 561–580 5)-TATGGGCGTGCAGATTTC AC (3)
Semi-nested 2
TE3 311–330 5)-CTTTTATACGAGGAG GGGA (3) 590-bp
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95°C, followed by 30 cycles of 94°C for 1 min, 55°C for
30 sec and 72°C for 45 sec, and a final incubation at 72°C
for 10 min. Thermal profiles were performed on a Techne
PHC-2 thermal cycler (Techne, Princeton, NJ.). Following
amplification, 15 µl from each PCR containing amplified
products were loaded onto gels of 1.5% SeaKem agarose
(FMC Bioproduct, Rockland ME) and electrophoresed.
The gels were stained with ethidium bromide and the
nested PCR products were easily identified following vis-
ualization under UV light.
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